Topic

Galafold (migalastat)

A collection of 34 issues

How to Get Galafold (Migalastat) Covered by UnitedHealthcare in Pennsylvania: Complete Guide with Forms, Appeals, and State Resources

Answer Box: Getting Galafold Covered by UnitedHealthcare in Pennsylvania Quick Path to Approval: UnitedHealthcare requires prior authorization for Galafold (migalastat) through OptumRx using Program 2024 P 1258-7. You need confirmed amenable GLA variant testing and cannot be on concurrent enzyme replacement therapy. Submit via the UnitedHealthcare Provider Portal or fax
6 min read

Galafold (Migalastat) Approval with UnitedHealthcare in Washington: Answers to the Most Common Questions

Answer Box: Getting Galafold Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Galafold (migalastat) with proof of Fabry disease diagnosis and an amenable GLA variant confirmed by in vitro assay. Initial approval lasts 12 months; reauthorization requires documented positive clinical response. If denied, Washington residents can appeal through
5 min read

Renewing Galafold (Migalastat) Coverage with UnitedHealthcare in Illinois: Timeline, Documentation, and Appeal Options

Answer Box: Renewing Galafold Coverage with UnitedHealthcare in Illinois UnitedHealthcare requires annual reauthorization for Galafold (migalastat) with documentation of positive clinical response. Submit renewal requests 30-60 days before expiration through OptumRx with specialist notes showing treatment response (reduced GL-3 levels, stable kidney function). If denied, you have 180 days for
6 min read

How to Get Galafold (Migalastat) Approved by Aetna CVS Health in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Galafold Approved by Aetna CVS Health in Michigan Aetna CVS Health requires prior authorization for Galafold (migalastat) in Michigan with 15-day standard or 72-hour expedited decisions. You'll need: confirmed Fabry disease diagnosis, documented amenable GLA variant, specialist prescription (nephrology/genetics/cardiology), and either ERT failure
7 min read